HC Wainwright & Co. Reiterates Buy on Immunocore Hldgs, Maintains $90 Price Target
HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $90 price target.
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell
• Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Immunocore Reveals First Data From HIV Infection Candidate Study
Immunocore Holdings plc (NASDAQ:IMCR) has presented the first safety and activity data with IMC-M113V, a bispecific soluble TCR therapy built on…
Goldman Sachs Upgrades Immunocore Hldgs to Buy
Goldman Sachs analyst Rajan Sharma upgrades Immunocore Hldgs (NASDAQ:IMCR) from Neutral to Buy.
HC Wainwright & Co. Maintains Buy on Immunocore Hldgs, Raises Price Target to $90
HC Wainwright & Co. analyst Patrick Trucchio maintains Immunocore Hldgs (NASDAQ:IMCR) with a Buy and raises the price target from $80 to $90.
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
Bill Gates has two portfolios he makes trades from: the Bill & Melinda Gates Foundation and the Bill & Melinda Gates Foundation Trust.
What 6 Analyst Ratings Have To Say About Immunocore Hldgs
Analysts have provided the following ratings for Immunocore Hldgs (NASDAQ:IMCR) within the last quarter:
JP Morgan Maintains Overweight on Immunocore Hldgs, Raises Price Target to $67
JP Morgan analyst Jessica Fye maintains Immunocore Hldgs (NASDAQ:IMCR) with a Overweight and raises the price target from $60 to $67.
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Gainers
Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.